天宇股份：坎地沙坦酯片完成药品注册

Core Viewpoint - Tianyu Co., Ltd. (300702.SZ) announced that its wholly-owned subsidiary, Zhejiang Node Pharmaceutical Co., Ltd., has received the drug registration certificate for Candesartan Cilexetil Tablets from the National Medical Products Administration, indicating the product's approval for the treatment of primary hypertension [1]. Company Summary - Tianyu Co., Ltd. has successfully obtained regulatory approval for Candesartan Cilexetil Tablets, which are indicated for primary hypertension [1]. - The approval enhances the product portfolio of Zhejiang Node Pharmaceutical Co., Ltd., potentially increasing its market presence in the hypertension treatment segment [1].